Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
This article explores how the role of regulatory T cells in immunological self-tolerance evolved from skepticism to Nobel ...
By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.
Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of death by more than half compared to standard of care ...
This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...
This year's two Japanese Nobel Prize winners spoke at separate venues in Stockholm ahead of Wednesday's Nobel Prize award ...
Avant Technologies Inc. ("Avant" or the "Company"), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders, today announced a newly ...
Ouster, Inc. ("Ouster" or the "Company"), a global leader in high-performance lidar sensors and intelligent software solutions that bring Physical AI to life across the automotive, industrial, ...
BioInvent International (STO:BINV)46% objective response rate (6 of 13 evaluable patients) and a 92% disease control rate (12 of 13) in relapsed/refractory CTCLImmune activation confirmed by CD8+ T ...
Autoimmune diseases, like multiple sclerosis result when the body's immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback